XML 56 R44.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation Expense (Tables)
 6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]    
Schedule of stock option award activity
Options  Shares   Weighted Average
Exercise Price		   Weighted Average Remaining Contractual Term 
             
Outstanding at December 31, 2020   10,975,224   $0.57    7.6 
Granted   627,160    9.04      
Exercised   (95,745)   0.24      
Cancelled or forfeited   (41,146)   8.11      
Outstanding at June 30, 2021   11,465,493   $1.01    7.1 
Exercisable at June 30, 2021   6,555,419   $0.26    6.2 

 
Options  Shares   Weighted
Average
Exercise Price		   Weighted
Average
Remaining
Contractual
Term		 
             
Outstanding at December 31, 2019   10,087,296   $     0.25    7.4 
Granted   2,738,912    1.76      
Exercised   (488,860)   0.24      
Cancelled or forfeited   (1,362,124)   0.74      
Outstanding at December 31, 2020   10,975,224   $0.57    7.6 
Exercisable at December 31, 2020   5,518,767   $0.25    6.4 

 
Schedule of fair value of restricted stock awards
   Number of Shares   Weighted Average Grant Date Fair Value Per Share 
         
Non-vested, at beginning of period   446,332   $0.24 
Granted   
-
    
-
 
Vested   
-
    
-
 
Cancelled or forfeited   
-
    
 
 
Non-vested, at end of period   446,332   $0.24 

 

   Number of Shares   Weighted Average Grant Date Fair Value Per Share 
         
Non-vested, at beginning of period   
-
   $
-
 
Granted   377,373    7.19 
Vested   
-
    
-
 
Cancelled or forfeited   (3,567)   14.17 
Non-vested, at end of period   373,806   $7.12 
   Number of
shares		   Weighted-average
grant-date fair
value per share		 
         
Non-vested, at beginning of period   446,332   $      0.24 
Granted   25,309    9.21 
Vested   (25,309)   9.21 
Cancelled or forfeited   
-
    
-
 
Non-vested, at end of period   446,332   $0.24